Biological predictors of survival in stage II colorectal cancer

The routine use of postoperative adjuvant chemotherapy in patients with stage II colorectal cancer is not recommended. However, the incidence of tumor recurrence or distant metastasis in these patients is reported to be 25–35%. The identification of high-risk patients with stage II colorectal cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: UEDA, YOSHITAKE, YASUDA, KAZUHIRO, INOMATA, MASAFUMI, SHIRAISHI, NORIO, YOKOYAMA, SHIGEO, KITANO, SEIGO
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915554/
https://www.ncbi.nlm.nih.gov/pubmed/24649222
http://dx.doi.org/10.3892/mco.2013.126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915554/
https://www.ncbi.nlm.nih.gov/pubmed/24649222
http://dx.doi.org/10.3892/mco.2013.126

Ejemplares similares